Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
An Open Label Single Center Pilot Study Investigating the Clinical Response and Mechanism of Action of Infliximab in the Treatment of Adults With Inflammatory Bowel Disease Who Have Moderate to Severe Pyoderma Gangrenosum An Open Label Single Center Pilot Study Investigating the Clinical Response and Mechanism of Action ...